Fridriksdottir Hafrun
Insider CIK 1561458 · ACT SVP, GLOBAL R&D · TEVA Executive VP, Global R&D · ACT Sr VP,Global Generics R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-05-17 | 2022-05-19 | 130,000 | $8.22 | $1.07M | 1,387 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-07 | 2022-03-08 | 8,941 | $7.37 | $65.9K | 126,087 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-05 | 2022-03-08 | 23,764 | — | $0 | 71,293 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-05 | 2022-03-08 | 23,764 | — | $0 | 135,028 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 18,905 | — | $0 | 18,906 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 51,488 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-03-04 | 2022-03-08 | 140,750 | — | $0 | 140,750 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 51,488 | — | $0 | 116,997 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-04 | 2022-03-08 | 18,020 | $7.48 | $134.8K | 98,977 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 18,905 | — | $0 | 117,882 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-03-04 | 2022-03-08 | 6,618 | $7.48 | $49.5K | 111,264 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-28 | 2022-03-02 | 21,682 | — | $0 | 43,366 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-02-28 | 2022-03-02 | 7,590 | $8.14 | $61.8K | 65,509 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-28 | 2022-03-02 | 21,682 | — | $0 | 73,099 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-09 | 2022-02-10 | 16,121 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2022-02-09 | 2022-02-10 | 6,116 | $9.06 | $55.4K | 51,417 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-09 | 2022-02-10 | 16,121 | — | $0 | 57,533 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-02-08 | 2022-02-10 | 51,488 | — | $0 | 51,488 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-08-10 | 2021-08-12 | 50,860 | $9.95 | $506.1K | 41,412 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-05-11 | 2021-05-13 | 37,884 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-05-11 | 2021-05-13 | 37,884 | — | $0 | 111,338 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-05-11 | 2021-05-13 | 19,066 | $10.22 | $194.9K | 92,272 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-03-05 | 2021-03-08 | 95,057 | — | $0 | 95,057 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-04 | 2021-03-08 | 18,905 | — | $0 | 37,811 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-04 | 2021-03-08 | 18,905 | — | $0 | 82,969 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-04 | 2021-03-08 | 9,515 | $10.57 | $100.6K | 73,454 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-02 | 2021-03-04 | 50,000 | $10.82 | $541.0K | 64,064 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-01 | 2021-03-02 | 10,912 | $10.83 | $118.2K | 114,064 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-28 | 2021-03-02 | 21,682 | — | $0 | 65,048 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-28 | 2021-03-02 | 21,682 | — | $0 | 124,976 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-16 | 2021-02-17 | 2,098 | $11.12 | $23.3K | 103,294 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-14 | 2021-02-17 | 5,355 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-14 | 2021-02-17 | 5,355 | — | $0 | 105,392 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-02-09 | 2021-02-11 | 37,884 | — | $0 | 37,884 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-09 | 2021-02-11 | 16,120 | — | $0 | 16,121 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 23,639 | $12.69 | $300.0K | 100,037 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-09 | 2021-02-11 | 16,120 | — | $0 | 61,681 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award | 2021-02-09 | 2021-02-11 | 67,852 | — | $0 | 129,533 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-02-09 | 2021-02-11 | 5,857 | $12.69 | $74.3K | 123,676 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-17 | 2020-03-19 | 266 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-03-17 | 2020-03-19 | 748 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-17 | 2020-03-19 | 134 | $7.16 | $959 | 45,561 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-17 | 2020-03-19 | 266 | — | $0 | 46,075 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-03-17 | 2020-03-19 | 748 | — | $0 | 45,809 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-03-17 | 2020-03-19 | 380 | $7.16 | $2.7K | 45,695 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-28 | 2020-03-03 | 86,730 | — | $0 | 86,730 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 5,353 | — | $0 | 5,355 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 17,850 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-14 | 2020-02-18 | 8,825 | $12.14 | $107.1K | 45,061 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 17,850 | — | $0 | 56,533 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 5,353 | — | $0 | 38,683 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-14 | 2020-02-18 | 2,647 | $12.14 | $32.1K | 53,886 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-11 | 2020-02-13 | 17,850 | — | $0 | 17,850 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-10 | 2020-02-11 | 5,544 | $12.27 | $68.0K | 33,330 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-09 | 2020-02-11 | 16,120 | — | $0 | 32,241 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-09 | 2020-02-11 | 16,120 | — | $0 | 38,874 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-12-31 | 2020-01-02 | 4,640 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-12-31 | 2020-01-02 | 4,640 | — | $0 | 25,213 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-12-31 | 2020-01-02 | 2,459 | $9.92 | $24.4K | 22,754 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-12-02 | 2019-12-03 | 4,310 | $10.49 | $45.2K | 20,573 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-11-30 | 2019-12-03 | 8,133 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-11-30 | 2019-12-03 | 8,133 | — | $0 | 24,883 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-18 | 2019-03-19 | 263 | $16.63 | $4.4K | 16,843 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-18 | 2019-03-19 | 93 | $16.63 | $1.5K | 16,750 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-17 | 2019-03-19 | 747 | — | $0 | 748 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-17 | 2019-03-19 | 265 | — | $0 | 266 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-17 | 2019-03-19 | 265 | — | $0 | 17,106 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-17 | 2019-03-19 | 747 | — | $0 | 16,841 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-03-04 | 2019-03-05 | 1,165 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-03-04 | 2019-03-06 | 56,716 | — | $0 | 56,716 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-03-04 | 2019-03-05 | 409 | $16.88 | $6.9K | 16,094 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-03-04 | 2019-03-05 | 1,165 | — | $0 | 16,503 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-02-14 | 2019-02-19 | 5,353 | — | $0 | 10,708 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-02-14 | 2019-02-19 | 5,353 | — | $0 | 17,179 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-02-14 | 2019-02-19 | 1,841 | $17.67 | $32.5K | 15,338 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2019-01-02 | 2019-01-03 | 1,643 | $15.70 | $25.8K | 11,826 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-12-31 | 2019-01-03 | 4,640 | — | $0 | 4,640 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-12-31 | 2019-01-03 | 4,640 | — | $0 | 13,469 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-11-30 | 2018-12-04 | 2,711 | — | $0 | 8,133 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-11-30 | 2018-12-04 | 2,711 | — | $0 | 9,762 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-11-30 | 2018-12-04 | 933 | $21.76 | $20.3K | 8,829 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-19 | 2018-03-20 | 257 | $17.88 | $4.6K | 7,142 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-03-19 | 2018-03-20 | 91 | $17.88 | $1.6K | 7,051 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-17 | 2018-03-20 | 265 | — | $0 | 531 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-17 | 2018-03-20 | 747 | — | $0 | 1,495 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-17 | 2018-03-20 | 747 | — | $0 | 7,134 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-17 | 2018-03-20 | 265 | — | $0 | 7,399 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-05 | 2018-03-06 | 3,432 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | F Tax w/h | 2018-03-05 | 2018-03-06 | 1,155 | $19.38 | $22.4K | 6,387 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | F Tax w/h | 2018-03-05 | 2018-03-06 | 400 | $19.38 | $7.8K | 7,542 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-05 | 2018-03-06 | 3,432 | — | $0 | 7,942 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-03-04 | 2018-03-06 | 1,165 | — | $0 | 1,165 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-03-04 | 2018-03-06 | 1,165 | — | $0 | 4,510 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 123,288 | — | $0 | 123,288 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 48,361 | — | $0 | 48,361 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 1,269 | $197.05 | $250.1K | 6,914 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 5,645 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 5,645 | — | $0 | 5,645 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-09-30 | 2013-10-02 | 5,110 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-09-30 | 2013-10-02 | 4,318 | — | $0 | 6,045 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-30 | 2013-10-02 | 5,510 | $144.00 | $793.4K | 5,645 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-09-30 | 2013-10-02 | 5,110 | — | $0 | 11,155 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 1,727 | — | $0 | 1,727 | SEC↗ |
| ACT Actavis, Inc. | A Award deriv | 2012-12-05 | 2013-10-02 | 5,110 | — | $0 | 5,110 | SEC↗ |